With decisive and timely action, genome-related biotechnology can be harnes
sed to improve global health equity. In June 2002 in Kananaskis, Canada, le
aders of the G8 industrial nations will develop an action plan to support i
mplementation of the New African Initiative. By extending their discussion
of health issues raised in the New African Initiative to include genomics,
G8 leaders could signal their intention to increase global health equity by
preventing a health genomics divide from developing. There are already som
e early and growing examples of genome-related biotechnology being applied
successfully to health problems in developing countries. But how can genomi
cs be systematically harnessed to benefit health in developing countries? W
e propose a five-point strategy, including research, capacity strengthening
, consensus building, public engagement, and an investment fund.